Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Citi notes that the FDA said in a status report filed in a Texas court that it needs more time to determine if Eli Lilly’s (LLY) tirzepatide ...

Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its obesity-related ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...

In a report released today, Daniel Grosslight from Citi maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a price target of $24.00. Don't Miss our Black Friday Offers: ...

To help its customers stay on top of their protein and nutrient intake and simplify access to the critical nutrition support they need, Hims & Hers announced its customers will now be able to have ...

The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five ...